Analytical Data
-
Gene name
NFAM1
- Application
-
Alternative Names
NFAM1; CNAIPNFAT activation molecule 1; Calcineurin/NFAT-activating ITAM-containing protein; NFAT-activating protein with ITAM motif 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NET5
-
Expression Region
1-270 aa
-
AA Sequence
MENQPVRWRALPGLPRPPGLPAAPWLLLGVLLLPGTLRLAGGQSVTHTGLPIMASLANTAISFSCRITYPYTPQFKVFTVSYFHEDLQGQRSPKKPTNCHPGLGTENQSHTLDCQVTLVLPGASATGTYYCSVHWPHSTVRGSGTFILVRDAGYREPPQSPQKLLLFGFTGLLSVLSVVGTALLLWNKKRMRGPGKDPTRKCPDPRSASSPKQHPSESVYTALQRRETEVYACIENEDGSSPTAKQSPLSQERPHRFEDDGELNLVYENL
-
Molecular Weight
56.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NFAM1 (Nuclear Factor Activator of Macrophages 1) is a transcription factor that has garnered interest due to its critical role in regulating immune responses and its involvement in various diseases, including cancer and autoimmune disorders. Research indicates that NFAM1 may participate in modulating the activation and differentiation of macrophages, influencing inflammatory responses and pathogen recognition. Understanding the function and pathways of NFAM1 is essential for elucidating its role in immune system dynamics. Furthermore, the study of NFAM1 recombinant protein is pivotal for investigating its potential as a therapeutic target. The production of recombinant NFAM1 allows for detailed analysis of its structure-function relationships and interactions with other cellular components, providing insight into its mechanistic roles in health and disease. As immune modulation becomes increasingly relevant in therapeutic strategies, characterizing NFAM1 may facilitate the development of novel treatments tailored for immunological conditions.











